NCAM1 and neoplasm: In the higher half subgroup of CD56+ immune cells infiltrating in tumor stroma, the relapse ratio was significantly lower in the vitamin D group (7.4%), than in the placebo group (20.5%), whereas in the lower half subgroup, relapse ratio was not different.